Latest Headlines

  1. Versatile Single Tube Decapper/Recapper Reduces Strain And Streamlines Workflow 3/13/2025

    Engineered to handle a wide range of large-format tubes—including centrifuge, cell culture, and glass sample tubes (11-40mm) - the IntelliXcap S1 from Azenta Life Sciences eliminates the inconvenience of manual adjustments by accommodating multiple tube types without requiring a cap gripper change.

  2. Children's Hospital Colorado Announces Innovative In-House Whole-Genome Sequencing Lab 3/12/2025

    The Children's Hospital Colorado (Children's Colorado) Precision Medicine Institute today announces the recent opening of its innovative whole-genome sequencing lab that is revolutionizing the hospital's capabilities to make genomic results accessible and integrated into patient care.

  3. Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer To Evolving Needs Of Fertility Clinics, Biorepositories And Clinical Laboratories 3/12/2025

    Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today announced the launch of MVE Biological Solutions' ("MVE") High-Efficiency 800 C, the latest addition to its next-generation High-Efficiency ("HE") Series of cryogenic freezers.

  4. Adaptive Biotechnologies Launches Assay Enhancements To Increase clonoSEQ® Sensitivity For Clinical MRD Detection In Diffuse Large B-Cell Lymphoma 3/11/2025

    Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced that it has launched an upgraded version of its clonoSEQ assay for measurable residual disease (MRD) detection in diffuse large B-cell lymphoma (DLBCL) using circulating tumor DNA (ctDNA).

  5. Guardant Health Receives ADLT Status From CMS For Shield Blood Test 3/11/2025

    Guardant Health, Inc. a leading precision oncology company, today announced the Centers for Medicare & Medicaid Services (CMS) has approved Advanced Diagnostic Laboratory Test (ADLT) status for the Shield blood test for colorectal cancer (CRC) screening.

  6. Labcorp Announces Acquisition Of Select Assets Of BioReference Health's Innovative Oncology And Related Clinical Testing Services Businesses 3/11/2025

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.

  7. Pramana And ARUP Laboratories Partner To Digitize Pathology Slides And Develop AI-Powered Hematopathology Algorithms For Deployment Via Edge AI 3/11/2025

    Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, and ARUP Laboratories, the largest nonprofit clinical and academic reference laboratory in the United States, announced a collaboration to digitize pathology slides and develop AI-powered algorithms to improve the assessment of bone marrow biopsies and address other key diagnostic challenges in hematopathology.

  8. Augurex Announces UK Conformity Assessed (UKCA) Authorization For JOINTstat, Expanding Access To Cutting-Edge Rheumatoid Arthritis Testing In Great Britain 3/10/2025

    Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, today announced that JOINTstat, the Company’s blood test for 14-3-3eta, has received UK Conformity Assessed (UKCA) marking.

  9. Beckman Coulter Announces FDA Clearance Of DxC 500i Clinical Analyzer, An Integrated Clinical Chemistry And Immunoassay System 3/10/2025

    Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k) clearance from the U.S. Food and Drug Administration.

  10. QuidelOrtho Introduces Results Manager System 3/10/2025

    QuidelOrtho Corporation (“QuidelOrtho”) announces the availability of the QuidelOrtho Results Manager System, an informatics solution designed to address the growing demands of modern laboratories.